Oct 2026
Virtual screening, structural optimization, computational studies, and biological evaluation of quinoline derivatives as selective butyrylcholinesterase inhibitors.
Butyrylcholinesterase (BChE) has been recognized as an important therapeutic target for neurodegenerative diseases, including Alzheimer's disease (AD). In this study, a molecular docking-based virtual screening strategy led to the identification of a novel BChE inhibitor, Hit 5 (eqBChE IC50 = 4.1 ± 0.19 μM, hBChE IC50 ...
Hua-Ke Gao, Fei-Fei Li, Qin Liu et al.
· Bioorganic chemistry (Print) · 0 citations